ID   PKHD1_MOUSE             Reviewed;        4059 AA.
AC   E9PZ36;
DT   10-FEB-2021, integrated into UniProtKB/Swiss-Prot.
DT   05-APR-2011, sequence version 1.
DT   07-APR-2021, entry version 79.
DE   RecName: Full=Fibrocystin {ECO:0000305};
DE   AltName: Full=Polycystic kidney and hepatic disease 1 protein;
DE   AltName: Full=Polyductin;
DE   Flags: Precursor;
GN   Name=Pkhd1 {ECO:0000312|MGI:MGI:2155808};
OS   Mus musculus (Mouse).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Mus; Mus.
OX   NCBI_TaxID=10090;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=C57BL/6J;
RX   PubMed=19468303; DOI=10.1371/journal.pbio.1000112;
RA   Church D.M., Goodstadt L., Hillier L.W., Zody M.C., Goldstein S., She X.,
RA   Bult C.J., Agarwala R., Cherry J.L., DiCuccio M., Hlavina W., Kapustin Y.,
RA   Meric P., Maglott D., Birtle Z., Marques A.C., Graves T., Zhou S.,
RA   Teague B., Potamousis K., Churas C., Place M., Herschleb J., Runnheim R.,
RA   Forrest D., Amos-Landgraf J., Schwartz D.C., Cheng Z., Lindblad-Toh K.,
RA   Eichler E.E., Ponting C.P.;
RT   "Lineage-specific biology revealed by a finished genome assembly of the
RT   mouse.";
RL   PLoS Biol. 7:E1000112-E1000112(2009).
RN   [2]
RP   INTERACTION WITH CAMLG.
RX   PubMed=16243292; DOI=10.1016/j.bbrc.2005.10.022;
RA   Nagano J., Kitamura K., Hujer K.M., Ward C.J., Bram R.J., Hopfer U.,
RA   Tomita K., Huang C., Miller R.T.;
RT   "Fibrocystin interacts with CAML, a protein involved in Ca2+ signaling.";
RL   Biochem. Biophys. Res. Commun. 338:880-889(2005).
RN   [3]
RP   PROTEOLYTIC PROCESSING, SUBCELLULAR LOCATION, AND REGION.
RX   PubMed=16956880; DOI=10.1074/jbc.m606740200;
RA   Hiesberger T., Gourley E., Erickson A., Koulen P., Ward C.J., Masyuk T.V.,
RA   Larusso N.F., Harris P.C., Igarashi P.;
RT   "Proteolytic cleavage and nuclear translocation of fibrocystin is regulated
RT   by intracellular Ca2+ and activation of protein kinase C.";
RL   J. Biol. Chem. 281:34357-34364(2006).
RN   [4]
RP   SHEDDING, AND SUBCELLULAR LOCATION.
RX   PubMed=17470460; DOI=10.1093/hmg/ddm039;
RA   Kaimori J.Y., Nagasawa Y., Menezes L.F., Garcia-Gonzalez M.A., Deng J.,
RA   Imai E., Onuchic L.F., Guay-Woodford L.M., Germino G.G.;
RT   "Polyductin undergoes notch-like processing and regulated release from
RT   primary cilia.";
RL   Hum. Mol. Genet. 16:942-956(2007).
RN   [5]
RP   DISRUPTION PHENOTYPE, SUBCELLULAR LOCATION, AND TISSUE SPECIFICITY.
RX   PubMed=18202188; DOI=10.2353/ajpath.2008.070381;
RA   Gallagher A.R., Esquivel E.L., Briere T.S., Tian X., Mitobe M.,
RA   Menezes L.F., Markowitz G.S., Jain D., Onuchic L.F., Somlo S.;
RT   "Biliary and pancreatic dysgenesis in mice harboring a mutation in Pkhd1.";
RL   Am. J. Pathol. 172:417-429(2008).
RN   [6]
RP   DISRUPTION PHENOTYPE, FUNCTION, AND INTERACTION WITH PKD2.
RX   PubMed=18235088; DOI=10.1681/asn.2007070770;
RA   Kim I., Fu Y., Hui K., Moeckel G., Mai W., Li C., Liang D., Zhao P., Ma J.,
RA   Chen X.Z., George A.L. Jr., Coffey R.J., Feng Z.P., Wu G.;
RT   "Fibrocystin/polyductin modulates renal tubular formation by regulating
RT   polycystin-2 expression and function.";
RL   J. Am. Soc. Nephrol. 19:455-468(2008).
RN   [7]
RP   DISRUPTION PHENOTYPE.
RX   PubMed=18286309; DOI=10.1007/s00467-007-0735-4;
RA   Williams S.S., Cobo-Stark P., James L.R., Somlo S., Igarashi P.;
RT   "Kidney cysts, pancreatic cysts, and biliary disease in a mouse model of
RT   autosomal recessive polycystic kidney disease.";
RL   Pediatr. Nephrol. 23:733-741(2008).
RN   [8] {ECO:0007744|PubMed:21183079}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21183079; DOI=10.1016/j.cell.2010.12.001;
RA   Huttlin E.L., Jedrychowski M.P., Elias J.E., Goswami T., Rad R.,
RA   Beausoleil S.A., Villen J., Haas W., Sowa M.E., Gygi S.P.;
RT   "A tissue-specific atlas of mouse protein phosphorylation and expression.";
RL   Cell 143:1174-1189(2010).
RN   [9]
RP   FUNCTION.
RX   PubMed=19959710; DOI=10.1681/asn.2009060603;
RA   Nishio S., Tian X., Gallagher A.R., Yu Z., Patel V., Igarashi P., Somlo S.;
RT   "Loss of oriented cell division does not initiate cyst formation.";
RL   J. Am. Soc. Nephrol. 21:295-302(2010).
RN   [10]
RP   SUBCELLULAR LOCATION, MUTAGENESIS OF CYS-3869; 3870-LEU-VAL-3871;
RP   3872-CYS-CYS-3873; 3874-TRP-PHE-3875; 3876-LYS--SER-3878;
RP   3879-LYS--LYS-3882 AND 3883-ILE--PRO-3885, PALMITOYLATION, INTERACTION WITH
RP   RAB8A, AND REGION.
RX   PubMed=20048263; DOI=10.1083/jcb.200910096;
RA   Follit J.A., Li L., Vucica Y., Pazour G.J.;
RT   "The cytoplasmic tail of fibrocystin contains a ciliary targeting
RT   sequence.";
RL   J. Cell Biol. 188:21-28(2010).
RN   [11]
RP   FUNCTION.
RX   PubMed=20875407; DOI=10.1016/j.yexcr.2010.09.012;
RA   Hu B., He X., Li A., Qiu Q., Li C., Liang D., Zhao P., Ma J., Coffey R.J.,
RA   Zhan Q., Wu G.;
RT   "Cystogenesis in ARPKD results from increased apoptosis in collecting duct
RT   epithelial cells of Pkhd1 mutant kidneys.";
RL   Exp. Cell Res. 317:173-187(2011).
RN   [12]
RP   DISRUPTION PHENOTYPE, GLYCOSYLATION, PROTEOLYTIC PROCESSING, AND
RP   SUBCELLULAR LOCATION.
RX   PubMed=22021705; DOI=10.1681/asn.2010111173;
RA   Bakeberg J.L., Tammachote R., Woollard J.R., Hogan M.C., Tuan H.F., Li M.,
RA   van Deursen J.M., Wu Y., Huang B.Q., Torres V.E., Harris P.C., Ward C.J.;
RT   "Epitope-tagged Pkhd1 tracks the processing, secretion, and localization of
RT   fibrocystin.";
RL   J. Am. Soc. Nephrol. 22:2266-2277(2011).
RN   [13]
RP   INTERACTION WITH ARF4, AND MUTAGENESIS OF CYS-3869; 3870-LEU-VAL-3871;
RP   3872-CYS-CYS-3873; 3879-LYS--LYS-3882 AND 3883-ILE--PRO-3885.
RX   PubMed=24586199; DOI=10.1371/journal.pgen.1004170;
RA   Follit J.A., San Agustin J.T., Jonassen J.A., Huang T., Rivera-Perez J.A.,
RA   Tremblay K.D., Pazour G.J.;
RT   "Arf4 is required for Mammalian development but dispensable for ciliary
RT   assembly.";
RL   PLoS Genet. 10:e1004170-e1004170(2014).
RN   [14]
RP   SUBCELLULAR LOCATION, MUTAGENESIS OF 3879-LYS--PRO-3885, AND INTERACTION
RP   WITH TULP3.
RX   PubMed=28154160; DOI=10.1083/jcb.201607095;
RA   Badgandi H.B., Hwang S.H., Shimada I.S., Loriot E., Mukhopadhyay S.;
RT   "Tubby family proteins are adapters for ciliary trafficking of integral
RT   membrane proteins.";
RL   J. Cell Biol. 216:743-760(2017).
RN   [15]
RP   TISSUE SPECIFICITY, PROTEOLYTIC PROCESSING, SUBCELLULAR LOCATION, AND
RP   GLYCOSYLATION.
RX   PubMed=28729032; DOI=10.1016/j.kint.2017.04.027;
RA   Outeda P., Menezes L., Hartung E.A., Bridges S., Zhou F., Zhu X., Xu H.,
RA   Huang Q., Yao Q., Qian F., Germino G.G., Watnick T.;
RT   "A novel model of autosomal recessive polycystic kidney questions the role
RT   of the fibrocystin C-terminus in disease mechanism.";
RL   Kidney Int. 92:1130-1144(2017).
CC   -!- FUNCTION: Promotes ciliogenesis in renal epithelial cells and therefore
CC       participates in the tubules formation and/or ensures the maintenance of
CC       the architecture of the lumen of the kidney (PubMed:18235088,
CC       PubMed:20875407). Has an impact on cellular symmetry by ensuring
CC       correct bipolar cell division through the regulation of centrosome
CC       duplication and mitotic spindle assembly and by maintaining oriented
CC       cell division (OCD) during tubular elongation through planar cell
CC       polarity (PCP) pathway (PubMed:19959710). During epithelial cell
CC       morphogenesis regulates also cell-cell and cell-matrix adhesion and
CC       participates in cell motility (By similarity). Promotes cell-cell
CC       contact through the positive regulation of PTK2 kinase activity leading
CC       to either positive regulation of epithelial cell proliferation through
CC       the HRAS/RAF1 pathways, or negative regulation of apoptosis through the
CC       PDK1/AKT1 pathway (PubMed:20875407). May act in collecting-duct and
CC       biliary differentiation (By similarity). May participate in the
CC       regulation of the cholangiocytes proliferation and the CCN2 production
CC       in an CXCL8-dependent manner (By similarity).
CC       {ECO:0000250|UniProtKB:E2RK30, ECO:0000250|UniProtKB:P08F94,
CC       ECO:0000269|PubMed:18235088, ECO:0000269|PubMed:19959710,
CC       ECO:0000269|PubMed:20875407}.
CC   -!- SUBUNIT: Interacts with CAMLG (PubMed:16243292). Interacts with PKD2
CC       (PubMed:18235088). Interacts (via CST) with ARF4; this interaction
CC       allows an efficient PKHD1 trafficking to the cilium (PubMed:24586199).
CC       Interacts (via CST) with RAB8A; this interaction controls trafficking
CC       through the endomembrane systeme and to the cilium (PubMed:20048263).
CC       Interacts (via CST) with TULP3; this interaction allows PKHD1
CC       trafficking to the cilium (PubMed:28154160).
CC       {ECO:0000269|PubMed:16243292, ECO:0000269|PubMed:18235088,
CC       ECO:0000269|PubMed:20048263, ECO:0000269|PubMed:24586199,
CC       ECO:0000269|PubMed:28154160}.
CC   -!- INTERACTION:
CC       E9PZ36; P49069: CAMLG; Xeno; NbExp=4; IntAct=EBI-11693075, EBI-1748958;
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000250|UniProtKB:P08F94};
CC       Single-pass membrane protein {ECO:0000255}. Cytoplasm
CC       {ECO:0000250|UniProtKB:P08F94}. Apical cell membrane
CC       {ECO:0000269|PubMed:18202188}. Cytoplasm, cytoskeleton, cilium basal
CC       body {ECO:0000250|UniProtKB:P08F94}. Cell projection, cilium
CC       {ECO:0000269|PubMed:17470460, ECO:0000269|PubMed:18202188,
CC       ECO:0000269|PubMed:20048263, ECO:0000269|PubMed:22021705,
CC       ECO:0000269|PubMed:28154160}. Cytoplasm, cytoskeleton, spindle
CC       {ECO:0000250|UniProtKB:P08F94}. Chromosome, centromere
CC       {ECO:0000250|UniProtKB:P08F94}. Nucleus {ECO:0000269|PubMed:16956880}.
CC       Secreted, extracellular exosome {ECO:0000269|PubMed:22021705,
CC       ECO:0000269|PubMed:28729032}. Secreted {ECO:0000269|PubMed:22021705,
CC       ECO:0000269|PubMed:28729032}. Endoplasmic reticulum
CC       {ECO:0000269|PubMed:28729032}. Golgi apparatus
CC       {ECO:0000269|PubMed:28729032}. Note=The intra-cellular C-terminal
CC       fragment (ICD) translocates to the nucleus and is not detected in
CC       primary cilia (PubMed:16956880, PubMed:28729032). The extracellular
CC       domain (PECD) traffics beyond the mid-Golgi and localizes on exosome
CC       like vesicles (ELVs) attached to the primary cilium (PubMed:22021705,
CC       PubMed:28729032). In the urine, the extracellular domain (PECD) exists
CC       as an highly abundant secreted form and a less abundant PECD form that
CC       is either tethered to or shed with the C-terminal fragment (PTM) in
CC       ELVs (PubMed:28729032). The majority of full length PKHD1 protein
CC       resides at the endoplasmic reticulum and cannot pass beyond the mid-
CC       Golgi apparatus and is not detected in primary cilia (PubMed:28729032).
CC       {ECO:0000269|PubMed:16956880, ECO:0000269|PubMed:22021705,
CC       ECO:0000269|PubMed:28729032}.
CC   -!- TISSUE SPECIFICITY: Expressed in bile ducts and distal nephron segments
CC       but is absent from the proximal tubule (PubMed:18202188). Expressed in
CC       pancreas and kidney but also in the liver (PubMed:28729032). Expressed
CC       primarily in the distal tubule and thick ascending limb of the loop of
CC       Henle, and at low-level in the proximal tubule before renal development
CC       is complete at P0 (PubMed:28729032). {ECO:0000269|PubMed:18202188,
CC       ECO:0000269|PubMed:28729032}.
CC   -!- PTM: Palmitoylated (PubMed:20048263). Palmitoylation facilitates the
CC       trafficking to the cilia and membrane targeting (PubMed:20048263).
CC       {ECO:0000269|PubMed:20048263}.
CC   -!- PTM: N-glycosylated. {ECO:0000269|PubMed:22021705,
CC       ECO:0000269|PubMed:28729032}.
CC   -!- PTM: Several proteolytic cleavages occur within the extracellular
CC       domain, whereas at least one cleavage occurs within the cytoplasmic
CC       domain (PubMed:16956880). Cleaved by a probable proprotein convertase
CC       which produces an extracellular domain (polyductin extracellular
CC       domain, (PECD)) and a C-terminal fragment (polyductin transmembrane
CC       fragment (PTM)) which are tethered together by disulfide bonds
CC       (PubMed:17470460, PubMed:28729032). This extracellular domain (PECD) is
CC       then shed from the primary cilium by activation of a member of the ADAM
CC       metalloproteinase disintegrins family, resulting in concomitant release
CC       of an intra-cellular C-terminal fragment (ICD) via a gamma-secretase-
CC       dependent process (PubMed:17470460, PubMed:28729032). The proteolytic
CC       cleavage of the C-terminal intracellular fragment (ICD) is controlled
CC       by cytosolic calcium concentration and activation of PKC
CC       (PubMed:16956880). {ECO:0000269|PubMed:16956880,
CC       ECO:0000269|PubMed:17470460, ECO:0000269|PubMed:28729032}.
CC   -!- DISRUPTION PHENOTYPE: A mouse model, for human autosomal recessive
CC       polycystic kidney disease (ARPKD), where homozygous knockout mice for
CC       the Pkhd1 gene are born at a frequency lower than the expected
CC       Mendelian ratio (PubMed:18235088). Homozygous mice may lead to
CC       embryonic lethality (PubMed:18235088). Mice that escape embryonic
CC       lethality and survive into adulthood exhibit mild to severe tubular
CC       dilation or cyst formation in the kidney and liver accompanied by
CC       fibrosis and necrosis (PubMed:18235088). Homozygous mice for the Pkhd1
CC       gene develop cysts and fibrosis in the liver at 1 month of age, and
CC       females develop proximal tubule (PT) dilation at 6 months of age
CC       whereas male mice never develop PT dilation (PubMed:22021705). Both
CC       male and female homozygous mice develop liver cysts and fibrosis at 3
CC       months of age and this worsens with age until the liver is completely
CC       replaced by cysts at 12 mo of age (PubMed:22021705). A new mouse model,
CC       for ARPKD, where homozygous knockout mice for the Pkhd1 gene develop
CC       biliary dysgenesis accompanied by periportal fibrosis. Despite the
CC       progressive liver disease, these mice are viable at 12 months of age
CC       with no apparent decline in synthetic liver function. These mice also
CC       develop extrahepatic phenotypes involving the pancreas, extrahepatic
CC       bile ducts, and spleen, which occur in a more variable manner
CC       (PubMed:18202188). An other model, for ARPKD, where homozygous knockout
CC       mice for the Pkhd1 gene develop progressive renal cystic disease
CC       involving the proximal tubules, collecting ducts, and glomeruli. In the
CC       liver, mice show dilatation of the bile ducts and periportal fibrosis.
CC       Dilatation of pancreatic exocrine ducts is uniformly seen, with
CC       pancreatic cysts arising less frequently (PubMed:18286309).
CC       {ECO:0000269|PubMed:18202188, ECO:0000269|PubMed:18235088,
CC       ECO:0000269|PubMed:18286309, ECO:0000269|PubMed:22021705}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AC101729; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC101789; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC161178; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC166488; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC166770; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   RefSeq; NP_694819.2; NM_153179.3.
DR   CORUM; E9PZ36; -.
DR   IntAct; E9PZ36; 1.
DR   STRING; 10090.ENSMUSP00000085794; -.
DR   SwissPalm; E9PZ36; -.
DR   MaxQB; E9PZ36; -.
DR   PaxDb; E9PZ36; -.
DR   PRIDE; E9PZ36; -.
DR   ProteomicsDB; 363285; -.
DR   Antibodypedia; 30875; 163 antibodies.
DR   GeneID; 241035; -.
DR   KEGG; mmu:241035; -.
DR   UCSC; uc007akv.1; mouse.
DR   CTD; 5314; -.
DR   MGI; MGI:2155808; Pkhd1.
DR   eggNOG; ENOG502QR85; Eukaryota.
DR   HOGENOM; CLU_000057_1_0_1; -.
DR   InParanoid; E9PZ36; -.
DR   OMA; ETVHNAD; -.
DR   OrthoDB; 323806at2759; -.
DR   TreeFam; TF329582; -.
DR   BioGRID-ORCS; 241035; 0 hits in 52 CRISPR screens.
DR   ChiTaRS; Pkhd1; mouse.
DR   Proteomes; UP000000589; Chromosome 1.
DR   RNAct; E9PZ36; protein.
DR   Bgee; ENSMUSG00000043760; Expressed in cortex of kidney and 84 other tissues.
DR   Genevisible; E9PZ36; MM.
DR   GO; GO:0097731; C:9+0 non-motile cilium; IDA:MGI.
DR   GO; GO:0016324; C:apical plasma membrane; IDA:UniProtKB.
DR   GO; GO:0005813; C:centrosome; ISO:MGI.
DR   GO; GO:0000775; C:chromosome, centromeric region; IEA:UniProtKB-SubCell.
DR   GO; GO:0036064; C:ciliary basal body; ISO:MGI.
DR   GO; GO:0005929; C:cilium; IDA:UniProtKB.
DR   GO; GO:0005737; C:cytoplasm; ISO:MGI.
DR   GO; GO:0005783; C:endoplasmic reticulum; IDA:UniProtKB.
DR   GO; GO:0070062; C:extracellular exosome; IDA:UniProtKB.
DR   GO; GO:0005794; C:Golgi apparatus; IDA:UniProtKB.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0072686; C:mitotic spindle; ISO:MGI.
DR   GO; GO:0005634; C:nucleus; IEA:UniProtKB-SubCell.
DR   GO; GO:0048471; C:perinuclear region of cytoplasm; ISO:MGI.
DR   GO; GO:0048754; P:branching morphogenesis of an epithelial tube; IMP:UniProtKB.
DR   GO; GO:0045216; P:cell-cell junction organization; IMP:UniProtKB.
DR   GO; GO:0006874; P:cellular calcium ion homeostasis; ISO:MGI.
DR   GO; GO:0060271; P:cilium assembly; IMP:MGI.
DR   GO; GO:0003382; P:epithelial cell morphogenesis; ISS:UniProtKB.
DR   GO; GO:0051660; P:establishment of centrosome localization; ISS:UniProtKB.
DR   GO; GO:0000132; P:establishment of mitotic spindle orientation; IMP:UniProtKB.
DR   GO; GO:0001822; P:kidney development; IDA:MGI.
DR   GO; GO:0043066; P:negative regulation of apoptotic process; ISO:MGI.
DR   GO; GO:1904036; P:negative regulation of epithelial cell apoptotic process; IMP:UniProtKB.
DR   GO; GO:0032088; P:negative regulation of NF-kappaB transcription factor activity; ISO:MGI.
DR   GO; GO:0051898; P:negative regulation of protein kinase B signaling; ISO:MGI.
DR   GO; GO:0008284; P:positive regulation of cell population proliferation; ISO:MGI.
DR   GO; GO:0050679; P:positive regulation of epithelial cell proliferation; IMP:UniProtKB.
DR   GO; GO:0030155; P:regulation of cell adhesion; ISS:UniProtKB.
DR   GO; GO:0022407; P:regulation of cell-cell adhesion; ISS:UniProtKB.
DR   GO; GO:0001952; P:regulation of cell-matrix adhesion; ISS:UniProtKB.
DR   GO; GO:0010824; P:regulation of centrosome duplication; ISO:MGI.
DR   GO; GO:1904054; P:regulation of cholangiocyte proliferation; ISS:UniProtKB.
DR   GO; GO:0070372; P:regulation of ERK1 and ERK2 cascade; ISO:MGI.
DR   GO; GO:0090175; P:regulation of establishment of planar polarity; IMP:UniProtKB.
DR   GO; GO:0032006; P:regulation of TOR signaling; ISO:MGI.
DR   Gene3D; 2.160.20.10; -; 1.
DR   Gene3D; 2.60.40.10; -; 5.
DR   InterPro; IPR039448; Beta_helix.
DR   InterPro; IPR019316; G8_domain.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR014756; Ig_E-set.
DR   InterPro; IPR002909; IPT_dom.
DR   InterPro; IPR037524; PA14/GLEYA.
DR   InterPro; IPR006626; PbH1.
DR   InterPro; IPR012334; Pectin_lyas_fold.
DR   InterPro; IPR011050; Pectin_lyase_fold/virulence.
DR   InterPro; IPR028839; PKHD1.
DR   PANTHER; PTHR46769:SF1; PTHR46769:SF1; 1.
DR   Pfam; PF13229; Beta_helix; 2.
DR   Pfam; PF10162; G8; 2.
DR   Pfam; PF01833; TIG; 6.
DR   SMART; SM01225; G8; 2.
DR   SMART; SM00429; IPT; 6.
DR   SMART; SM00710; PbH1; 8.
DR   SUPFAM; SSF51126; SSF51126; 2.
DR   SUPFAM; SSF81296; SSF81296; 6.
DR   PROSITE; PS51484; G8; 2.
DR   PROSITE; PS51820; PA14; 1.
PE   1: Evidence at protein level;
KW   Cell membrane; Cell projection; Centromere; Chromosome; Cytoplasm;
KW   Cytoskeleton; Endoplasmic reticulum; Glycoprotein; Golgi apparatus;
KW   Membrane; Nucleus; Reference proteome; Repeat; Secreted; Signal;
KW   Transmembrane; Transmembrane helix.
FT   SIGNAL          1..18
FT                   /evidence="ECO:0000255"
FT   CHAIN           19..4059
FT                   /note="Fibrocystin"
FT                   /evidence="ECO:0000255"
FT                   /id="PRO_5003243036"
FT   TOPO_DOM        19..3851
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000305"
FT   TRANSMEM        3852..3872
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        3873..4059
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000305"
FT   DOMAIN          25..109
FT                   /note="IPT/TIG 1; atypical"
FT                   /evidence="ECO:0000250|UniProtKB:P08F94"
FT   DOMAIN          135..230
FT                   /note="IPT/TIG 2"
FT                   /evidence="ECO:0000250|UniProtKB:P08F94"
FT   DOMAIN          257..333
FT                   /note="IPT/TIG 3"
FT                   /evidence="ECO:0000255"
FT   DOMAIN          323..483
FT                   /note="PA14"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01164"
FT   DOMAIN          945..997
FT                   /note="IPT/TIG 4"
FT                   /evidence="ECO:0000255"
FT   DOMAIN          1017..1100
FT                   /note="IPT/TIG 5"
FT                   /evidence="ECO:0000255"
FT   DOMAIN          1106..1190
FT                   /note="IPT/TIG 6; atypical"
FT                   /evidence="ECO:0000250|UniProtKB:P08F94"
FT   DOMAIN          1198..1266
FT                   /note="IPT/TIG 7"
FT                   /evidence="ECO:0000255"
FT   DOMAIN          1297..1378
FT                   /note="IPT/TIG 8; atypical"
FT                   /evidence="ECO:0000250|UniProtKB:P08F94"
FT   DOMAIN          1385..1466
FT                   /note="IPT/TIG 9"
FT                   /evidence="ECO:0000255"
FT   DOMAIN          1482..1566
FT                   /note="IPT/TIG 10"
FT                   /evidence="ECO:0000250|UniProtKB:P08F94"
FT   DOMAIN          1569..1637
FT                   /note="IPT/TIG 11"
FT                   /evidence="ECO:0000255"
FT   DOMAIN          1654..1738
FT                   /note="IPT/TIG 12; atypical"
FT                   /evidence="ECO:0000250|UniProtKB:P08F94"
FT   DOMAIN          1928..2049
FT                   /note="G8 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00817"
FT   REPEAT          2244..2266
FT                   /note="PbH1 1"
FT                   /evidence="ECO:0000255"
FT   REPEAT          2287..2321
FT                   /note="PbH1 2"
FT                   /evidence="ECO:0000255"
FT   REPEAT          2404..2426
FT                   /note="PbH1 3"
FT                   /evidence="ECO:0000255"
FT   REPEAT          2459..2481
FT                   /note="PbH1 4"
FT                   /evidence="ECO:0000255"
FT   DOMAIN          2741..2867
FT                   /note="G8 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00817"
FT   REPEAT          3004..3026
FT                   /note="PbH1 5"
FT                   /evidence="ECO:0000255"
FT   REPEAT          3027..3049
FT                   /note="PbH1 6"
FT                   /evidence="ECO:0000255"
FT   REPEAT          3080..3102
FT                   /note="PbH1 7"
FT                   /evidence="ECO:0000255"
FT   REPEAT          3188..3212
FT                   /note="PbH1 8"
FT                   /evidence="ECO:0000255"
FT   REGION          3869..3886
FT                   /note="Ciliary targeting sequence (CST)"
FT                   /evidence="ECO:0000269|PubMed:20048263"
FT   REGION          3946..3970
FT                   /note="Nuclear localization signal (NLS)"
FT                   /evidence="ECO:0000269|PubMed:16956880"
FT   SITE            3613..3614
FT                   /note="Cleavage"
FT                   /evidence="ECO:0000250|UniProtKB:P08F94"
FT   CARBOHYD        55
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00498"
FT   CARBOHYD        224
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00498"
FT   CARBOHYD        355
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00498"
FT   CARBOHYD        385
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00498"
FT   CARBOHYD        518
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00498"
FT   CARBOHYD        527
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00498"
FT   CARBOHYD        620
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00498"
FT   CARBOHYD        639
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00498"
FT   CARBOHYD        709
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00498"
FT   CARBOHYD        867
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00498"
FT   CARBOHYD        965
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00498"
FT   CARBOHYD        975
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00498"
FT   CARBOHYD        1082
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00498"
FT   CARBOHYD        1114
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00498"
FT   CARBOHYD        1133
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00498"
FT   CARBOHYD        1239
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00498"
FT   CARBOHYD        1273
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00498"
FT   CARBOHYD        1308
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00498"
FT   CARBOHYD        1319
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00498"
FT   CARBOHYD        1344
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00498"
FT   CARBOHYD        1373
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00498"
FT   CARBOHYD        1456
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00498"
FT   CARBOHYD        1471
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00498"
FT   CARBOHYD        1528
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00498"
FT   CARBOHYD        1613
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00498"
FT   CARBOHYD        1627
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00498"
FT   CARBOHYD        1694
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00498"
FT   CARBOHYD        1760
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00498"
FT   CARBOHYD        1775
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00498"
FT   CARBOHYD        1875
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00498"
FT   CARBOHYD        1879
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00498"
FT   CARBOHYD        1915
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00498"
FT   CARBOHYD        1955
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00498"
FT   CARBOHYD        2030
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00498"
FT   CARBOHYD        2139
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00498"
FT   CARBOHYD        2380
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00498"
FT   CARBOHYD        2466
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00498"
FT   CARBOHYD        2503
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00498"
FT   CARBOHYD        2529
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00498"
FT   CARBOHYD        2547
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00498"
FT   CARBOHYD        2581
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00498"
FT   CARBOHYD        2589
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00498"
FT   CARBOHYD        2627
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00498"
FT   CARBOHYD        2747
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00498"
FT   CARBOHYD        2762
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00498"
FT   CARBOHYD        3051
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00498"
FT   CARBOHYD        3133
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00498"
FT   CARBOHYD        3162
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00498"
FT   CARBOHYD        3218
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00498"
FT   CARBOHYD        3719
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00498"
FT   CARBOHYD        3831
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00498"
FT   MUTAGEN         3869
FT                   /note="C->A: Almost completely blocks the ability to
FT                   traffic to the cilia; when associated with 3872-A-A-3873.
FT                   Affects palmitoylation; when associated with 3872-A-A-3873.
FT                   Disrupts interaction with RAB8A; when associated with 3872-
FT                   A-A-3873. Disrupts interaction with ARF4; when associated
FT                   with 3872-A-A-3873."
FT                   /evidence="ECO:0000269|PubMed:20048263,
FT                   ECO:0000269|PubMed:24586199"
FT   MUTAGEN         3870..3871
FT                   /note="LV->AA: Little affects the ability to traffic to the
FT                   cilia. Does not affect interaction with RAB8A. Does not
FT                   affect interaction with ARF4."
FT                   /evidence="ECO:0000269|PubMed:20048263,
FT                   ECO:0000269|PubMed:24586199"
FT   MUTAGEN         3872..3873
FT                   /note="CC->AA: Almost completely blocks the ability to
FT                   traffic to the cilia; when associated with A-3869. Affetcs
FT                   palmitoylation; when associated with A-3869. Disrupts
FT                   interaction with RAB8A; when associated with A-3869.
FT                   Disrupts interaction with ARF4; when associated with A-
FT                   3869."
FT                   /evidence="ECO:0000269|PubMed:20048263,
FT                   ECO:0000269|PubMed:24586199"
FT   MUTAGEN         3874..3875
FT                   /note="WF->AA: Reduces the ability to traffic to the cilia.
FT                   Reduces interaction with RAB8A."
FT                   /evidence="ECO:0000269|PubMed:20048263"
FT   MUTAGEN         3876..3878
FT                   /note="KKS->AAA: Reduces the ability to traffic to the
FT                   cilia."
FT                   /evidence="ECO:0000269|PubMed:20048263"
FT   MUTAGEN         3879..3885
FT                   /note="KTRKIKP->AAAAAAA: Prevents ciliary localizytion."
FT                   /evidence="ECO:0000269|PubMed:28154160"
FT   MUTAGEN         3879..3882
FT                   /note="KTRK->AAAA: Almost completely blocks the ability to
FT                   traffic to cilia. Disrupts interaction with RAB8A. Disrupts
FT                   interaction with ARF4."
FT                   /evidence="ECO:0000269|PubMed:20048263,
FT                   ECO:0000269|PubMed:24586199"
FT   MUTAGEN         3883..3885
FT                   /note="IKP->AAA: Reduces the ability to traffic to the
FT                   cilia. Reduces interaction with RAB8A. Does not affect
FT                   interaction with ARF4."
FT                   /evidence="ECO:0000269|PubMed:20048263,
FT                   ECO:0000269|PubMed:24586199"
SQ   SEQUENCE   4059 AA;  444882 MW;  E36B773589027AC2 CRC64;
     MMLAWLVSLL SMEVLLLAKP YSSFQFEPAE GSLAGGTWIT VVFDGLDRSI LYPNNGSQLQ
     IDLVSVAIPT LRIPCDVSPA FVDLPVVTCQ TRSLPSEADA GPYSLEMRSG EQVLGTPCPG
     SLDSCTFKFS KDQTPVLYQV YPASGVPGEV VSVYGRVITT WLETFDPDVD YIESPLILEA
     REDKWLTPCS LINRQTGSCF PIQEEHGLGN VQCRVEGDYI GSQNVSFSVF NKGRSMVHKE
     AWLISAKQEL FLYQTYPEIL SVFPKVGSLG GRTDIIITGD FFDPSARVTI AGIPCDIRYV
     SPRKIECTTR APGNEARLTA PQAGNRGLRF EVGDATKDVE LTEATPGYRW QIVPNASSPS
     GFWSKEGRPF RARLSGFFVA PQTNNYTFWI QADSQASLCF SSSEEPRTKV EVASVGVGTA
     DWFDSWEQIG NEGSWHQKTT KLELQGGAKY YLEAEQHGIA PSRGMRIGVQ IHNTWLNPDV
     VNTYLLEKHQ IRARAQRLPE IQVLHVSGKG NFFLTWGNVS SQPVPANATA QQIQTTIEEL
     LVVKCNLAPF SAHVLLRLGF EQGLEGSRSD GVRTSSTEPF CGRFSLGQLG HLILIPEAAD
     KGYQLDRYPY LCLAYRGHMN KTLDMTVSFL FGFQTIMKNI TCDWSLTDPH PESWQFTCIN
     LWDTCLCHSE DIQSSLANTP LLAHRIDIRP VVPEAGLLYV DEIILADTNV TVSQADSGRA
     CPGGNVVESV SVVGVPPVYS ISSWLAGCGS ELPLITACSV STEGTGDGSE LIEVTAQRLQ
     RTSPPLGGHF FLYLSDTVIP DVPVRMSARQ LHKLLQDSAD ESTSGYLNAG DFTVTEDLNS
     CYEHVWTLSW TTQTGDLPNF IRVSDQNLTG VNPTVTARVV YDGGVFLGPI FGDMLATANQ
     QTQVAVQVND IPAYCSGSCS FQYQQESTPS VDHVWYSLGS DVNLLVHFTG TGFPRDTQFL
     QVTVNKTSCE VLFSNETNVA CELALLPVGV HQIFMLVIPS GLAVHASGED LLLHVEPRLD
     AVEPSTAAEI GGRWVTLRGS SLEGVSLVLF GTQSCVIDAI RSNSQQIQCK VPPRGKDGYT
     VNVTVISGDH STVLARAFTY VSSLNPVIVS LSRNRSSIAG GEILFLGMSL LVNYTDLDVQ
     IHVQDTSAQV LSQTAWGLEV VLPPLVPGIH VISAFINGVS IRSQGVDLYI QYLTEVFSVE
     PCSGSLLGGT LLSLLGTGLG RDPALIRVLV DNHPCDIVNL TEVNIWCETP PAVLPPRADV
     LTVLASVEIW AGNTSFFHGP SLVGKGFTFT YEAAATPVVT AMWGEFRNNS VRFYVEGSNI
     SDSVILLGSL KCELEVQFFG DSMNLSGCFF PLHSLEAGVY TLQVRHKRMG FANMSVVPQK
     FELSPQIIAI FPTHGSKCGG TVLTVKGMAF SSRKRSVHVD ISGPFACMIL SLEDHTVLCQ
     TRFVGDQFSE ASLALNITVL VNGLTSKCKG NCTLFIEEAA TPIVDALTIS ISGSLTMVLM
     RGRRLATTAD EPIAFVDDQL PCHTTFFNTS HVACQIRDLA PGFHYLSAVH TSAGYACLNS
     VSRNFFIVPQ VLDYFPKDFS IHGGSLLTIK GTALRGWKAT VVYVGRQACL TVNFSSDFIQ
     CIVPAGNGSA ALEIDVNGVL YHIGLVDYSS IFTPELLSVS RSQDILTFTV ARISGAANVD
     IFIGTSPCLG VAGNRTVLQC MVPLLPAGEY LVTGYDHSRG WASSTLILVL RATVTSVTKN
     YGCLGGRLLH VLGAGFSPGN ISAAVCGAPC QVLANATVSA FSCLVLPLHV SLAFLCDLRH
     AEDSCKVRSS TYLRCDLTVS MGTERLPGSW PYVYLCEESS LCLFEPDHWT ESVFPSFSGL
     FLSPKVERDE VLIYNSSCNI TMETEAEMEC EMPNQPITAK ITEIQKSWGQ NTQGNFSFQF
     CRRWSRPHSW FPQRVPHDGD SVTVETGHLL LLDANTSFLN SLHIKGGKLI FMDPGPIELR
     AHSILITDGG ELHIGSEEKP FQGKARIKIY GSVHSTPFFP YGVKFLAVRN GTLSLHGSVP
     EVTVTYLQAA AHAGDKVLTL GEAVDWKPGD EAVITSGMTV AGAEATEVVV VETVHNADLH
     LRNPLRYSYD FRENWVAGEN PILKPTVALL SRNIIIQGNF TLERVKLLNS CQEANTAKGN
     LKHCLYSKSE KMLGARDLGA RVIIQSFPEE PSFVKLKGVQ FRDLGQAFHK HLSSLALVGA
     MRGSYIQSCS VWNSFSRGLS MHRTWGLKVD SNVFYKIVGH ALLLGSYLDG RFSTSETVTG
     RKNGWWEQGS TIRNNVIISV SAAEGLSGSE MLAPAGIYTF SPTNVMEGNR VCAAGYGYVF
     HLVTSQTLQA PLLSFNWNTA HSCTRYGLLV YPKFQPPWNN DTGFTLFQNF MVWGSAGGAQ
     IFRSNNLHLK NFQVYACRDF GIDILESDAN TLITDSFLLG HFTHKGSLCM SAGIKTPQRW
     ELTISNTTFV NFDGNCVAIR TCSGCFQGQG GYTVKTRQLK FVNSSNLVAF PFPHAAVLED
     LDGSLSGKNG SHVLASMETL SDTCLTNASF SQIVPGSVCG EAVLFHRMSI ALANSLDVPK
     NLTITDISNK TITVNYVEDT LSNYYGWMAL LLDQETYSLQ FESPWMNRSL QYSATFDSFA
     PGNYLLIMHR DLPPYPDILL RCGSQVGHSL PFHPLPSQDR ACDWFFNRQL RQLTYLVSGE
     GQVKVFLQLK PGVPPSVSAS TSVPESASRW SLPETWQDVE KGWGGYNHTI PGPGDDVLIL
     PNKTVLVDTD LPVLRCLYVM GTLEFPVDRS NVLSVACLLI AGGELKVGTL ENPLEKDQRL
     LIFLRASEEV VCDYFEGIHV DPGTIGVYGK LRLHSAYPKK SWVHLGADIA PGNERIIVHN
     AVDWQPHDTI VLSSSSYEAH EAEVLTVKEV KGHHIRIYER LKHRHIGSTH TMEDGQQVHL
     AAEVGLLTRN IRIQPDSSCR GRLLVGSFRK SSGEDFSGVL QLLNVEIQNM GLPLYSSIEF
     TGVSAGSWVI SSTVHQSCSV GIHASSSHGV ILTDNVVFGT NGHGIDVEGQ NYSLTNNLVI
     LTMQSANSSP WVAGIKVNYA EDIILHGNVV AGSERLGFHV GGHGCSSEVL WSDNVVHSSL
     HGLHLYKKHE SNNCTGVSGF MAFKNFDYGA MVQTENSVDI QNITLVDNTV GLLAITYVSS
     ALLSSVSTVQ ITLRNSVIVA TSSSFDCIHD RKAPQSANWT STDRAPSNPR GGRIGILWPV
     SASEPNAWPQ EPWHKVRSRH SVPGIMKLQD VTFSSFVKSC YSNDLDVCIL PNEYSTGVMY
     PITAERTRML GIKDKNKFYF PVLQSSKDLV GTICPTLVCE YPRKYLFTDL DGRTLGLPPP
     VSVFPRTEEE WTGSFLNTGI FREEQKCTFR AMNQGFFCKQ TEHAVLILDN VDATWTIPKS
     HPLVSVTNGF VDTFSIVKDS DLCPPTSSLS TFYSILPTRQ MTKVCFPEQT PPFLRFLLLG
     NQRASKLILA VFYNEIQSPH VFLDKSFIPP TPLESAFSLL AEPSGANYFD IMNNLLYVVL
     QGEEPVEIHS SVSIHLALTV TFSVLEKGWE RAMLESLSDF FQIDPNQIRL TLEMPGNKET
     LEAIANSERK RKRNCPSVTC GGPSIRYGQR RPLMAEMTSL KITPATTLET FSKVIVIEVG
     DLPNIRNSEP IQSLPSNRLQ RLVNQVITAQ QTGALENVLG MTVGALLVTQ SKGVTGYRNA
     SSLITGNLIY TRPSELSILV QPSDGEVGIE LPVQPRLVFL DEKNERVESL GLPSEPWIIS
     VSLEGASESV LKGCTLAETR DGYVTFSRLA VLISGSNWHL FFTVISPPGT NFTARSRTFV
     VLPVASKERS TIILALSLCS VASWVALSCL VCCWFKKSKT RKIKPEDISE SQAKEQKKNT
     HNSSKPRGLQ AKTAKENTLM GEDMRMKVMQ GMQSQFPQHS MDGVSKRKVS RLAVTEERTT
     TPAPKIPRIT CVPGSLAQQL TLQEPGNWQE AQQQLLRYQL AGRNQLLLLR PDLRQERKQG
     QEPSQLDKGS DCTGLSQEKA TCIPTETFSL HTAPPETIQ
//
